Here, we engineered an insulin-Fc analog as a unique ASI that avoided binding to and activation of the insulin metabolic receptor while maintaining conformal integrity to bind and delete insulin-reactive B cells (via ADCC) that was associated with diabetes prevention in mice via an immune tolerance mechanism. The gene discussed is INS; the disease is diabetes mellitus.